A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects

Clinical trial NCT05253209 · TERMINATED

Trial details

NCT number: NCT05253209
Sponsor: Asklepion Pharmaceuticals, LLC
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Ventricular Septal Defect Atrioventricular Septal Defect Primum Atrial Septal Defect

Start date: 2022-06-29
Primary completion: 2024-05-10
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.